Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, McGill University, Montréal, Quebec, H3A 0G4, Canada.
MUHC Reproductive Centre, McGill University, Montréal, Quebec, H2L 4S8, Canada.
J Assist Reprod Genet. 2020 Mar;37(3):689-692. doi: 10.1007/s10815-020-01711-y. Epub 2020 Feb 26.
Recently, we have witnessed a shift in the nature of genetic testing. What was once solely in the hands of the scientific community is now easily accessible to anyone. Commercial companies such as Veritas Genetics, Ancestry, and 23andMe offer cheap direct-to-consumer home DNA kits that are branded as a "health and ancestry service." These tests are gaining in popularity, and it is estimated that since their marketing, over 30 million people worldwide have provided their DNA samples. The implications of this new genetic era are diverse, ranging from the individuals personal health assessment, to family genealogy and ancestry, and the complexity of establishing an enormous population-based genetic database. Unique implications of commercial DNA tests on fertility patients and heath care providers, such as in the case of gamete donation, are important to acknowledge and have implications for reproductive care.
最近，我们见证了基因检测性质的转变。曾经仅掌握在科学界手中的技术，现在任何人都可以轻松获取。Veritas Genetics、Ancestry 和 23andMe 等商业公司提供廉价的直接面向消费者的家用 DNA 试剂盒，这些试剂盒被标榜为“健康和祖源服务”。这些测试越来越受欢迎，据估计，自推出以来，全世界已有超过 3000 万人提供了他们的 DNA 样本。这个新的基因时代的影响是多方面的，从个人的健康评估，到家庭基因alogy 和祖源，再到建立庞大的基于人群的基因数据库的复杂性。商业 DNA 测试对生育患者和医疗保健提供者的独特影响，例如配子捐赠，是需要承认的，并且对生殖护理有影响。
